Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 08, 2026 31.84M
October 07, 2026 35.50M
October 06, 2026 31.64M
October 05, 2026 32.82M
October 02, 2026 33.77M
October 01, 2026 38.81M
September 30, 2026 34.83M
September 29, 2026 31.52M
September 28, 2026 33.57M
September 25, 2026 32.35M
September 24, 2026 34.40M
September 23, 2026 33.81M
September 22, 2026 35.85M
September 21, 2026 36.64M
September 18, 2026 38.61M
September 17, 2026 37.04M
September 16, 2026 33.33M
September 15, 2026 33.33M
September 14, 2026 37.19M
September 11, 2026 39.28M
September 10, 2026 38.85M
September 09, 2026 44.48M
September 08, 2026 42.51M
September 04, 2026 44.72M
September 03, 2026 45.19M
Date Value
September 02, 2026 44.91M
September 01, 2026 39.20M
August 31, 2026 39.40M
August 28, 2026 40.82M
August 27, 2026 42.55M
August 26, 2026 45.58M
August 25, 2026 46.92M
August 24, 2026 46.84M
August 21, 2026 44.34M
August 20, 2026 43.65M
August 19, 2026 42.92M
August 18, 2026 37.35M
August 17, 2026 36.68M
August 14, 2026 31.99M
August 13, 2026 34.87M
August 12, 2026 38.53M
August 11, 2026 43.50M
August 10, 2026 48.42M
August 07, 2026 52.67M
August 06, 2026 49.68M
August 05, 2026 48.81M
August 04, 2026 39.63M
August 03, 2026 40.93M
July 31, 2026 40.78M
July 30, 2026 42.08M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.488B
Alnylam Pharmaceuticals, Inc. 29.71B
Savara, Inc. 849.45M
Vericel Corp. 1.982B
Biogen, Inc. 39.33B

Enterprise Value Related Metrics